Literature DB >> 7010532

Interaction of cytopathogenic toxin from Clostridium difficile with cells in tissue culture.

M Thelestam, M Brönnegård.   

Abstract

Partially purified cytopathogenic toxin from Clostridium difficile induced morphological changes in five cell lines in tissue culture. The relative sensitivity scale of the cell lines was human lung and intestinal fibroblasts greater than Chinese hamster ovary cells much greater than mouse adrenal cells greater than mouse neuroblastoma cells. The cytopathogenic effect did not occur in toxin-treated lung fibroblasts incubated at 0 degree C. Pre-incubation of lung fibroblasts with 2,4-dinitrophenol prevented the cytopathogenic effect. The toxin bound to as yet unidentified receptors at the surface of human lung and intestinal fibroblasts. The toxin-induced morphological (actinomorphic) changes in lung and intestinal fibroblasts closely resembled the effects induced by the fungal metabolite cytochalasin B (CB), which is known to disrupt microfilaments reversibly. Indirect immunofluorescence with anti-actin antiserum demonstrated that the C. difficile toxin disrupted the straight actin filament bundles seen in normal fibroblasts. The cytopathogenic effect became apparent 3--5 h after exposure to toxin. However, irreversible intoxication occurred already within 20 min of exposure, as toxin-treated fibroblasts which were trypsinized and reseeded were not able to attach to the solid substratum and regenerate their typical shape, a process requiring reorganization of actin into microfilament bundles. Two possible different modes of action of the toxin, leading to microfilament disruption, are suggested: 1) Transmembrane signal by surface-bound toxin via microfilament-linked integral membrane protein(s) and 2) Penetration of surface-bound whole toxin or an active fragment, followed by its intracellular action. The experimental evidence so far is consistent with either of these mechanisms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7010532

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  19 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Effect of Clostridium difficile enterotoxin A on ultrastructure of Chinese hamster ovary cells.

Authors:  V M Kushnaryov; J J Sedmak
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

3.  NSP4 enterotoxin of rotavirus induces paracellular leakage in polarized epithelial cells.

Authors:  F Tafazoli; C Q Zeng; M K Estes; K E Magnusson; L Svensson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.

Authors:  T Peláez; L Alcalá; R Alonso; A Martín-López; V García-Arias; M Marín; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Biochemical studies on the effect of Clostridium difficile toxin B on actin in vivo and in vitro.

Authors:  M J Mitchell; B E Laughon; S Lin
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

6.  Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin.

Authors:  I Florin; M Thelestam
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

Review 7.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

8.  Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.

Authors:  M Giry; M R Popoff; C von Eichel-Streiber; P Boquet
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

Authors:  H C Krivan; G F Clark; D F Smith; T D Wilkins
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 10.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.